MAI Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Hold
0
1060
2026
Q1
Hold
0
1059
2025
Q4
Hold
0
935
2025
Q3
Hold
0
1221
2025
Q2
Hold
0
1293
2025
Q1
Hold
0
1192
2024
Q4
Hold
0
1242
2022
Q3
Sell
-1,300
Closed -$421K 998
2022
Q2
$421K Hold
1,300
0.01% 588
2022
Q1
$372K Buy
+1,300
New +$335K 0.01% 639
2021
Q3
Sell
-500
Closed -$115K 835
2021
Q2
$115K Hold
500
﹤0.01% 723
2021
Q1
$93K Buy
+500
New +$97.8K ﹤0.01% 694

Other funds holding LLY

MAI Capital Management's LLY Position: Q2 2026 in Review

MAI Capital Management increased its Eli Lilly (LLY) stake by 33% in Q2 2026, buying an estimated $31.9M and bringing the position to 127,320 shares worth $153M. The position accounts for 0.57% of the portfolio, ranked #36.

MAI Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MAI Capital Management held 127,320 shares of Eli Lilly worth $153M as of Q2 2026.
  • MAI Capital Management bought 31,231 Eli Lilly shares in Q2 2026, an estimated $31.9M.
  • Eli Lilly made up 0.57% of MAI Capital Management's portfolio in Q2 2026, its #36 holding.
  • MAI Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.